Moreover, the ghrelin signalling pathway may represent novel therapeutic opportunities for obesity-associated inflammatory diseases including diabetes and cancers due to the anti-inflammatory properties of various ghrelin gene products23,24. This evidence concerns the gene GHRL and obesity disorder.